Metraipolis › archive › dc_f88e485759f9

Longitudinal plasma proteomics identifies diagnostic and response-associated inflammatory and immune biomarkers in psoriasis following secukinumab therapy — Europe PMC PMID:42112372

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42112372
DOI
10.3389/fimmu.2026.1806248
License (as archived)
solo-consultazione
Archived
2026-11-03T06:23:14.927Z
SHA-256 of the archived text
088ee5314df5a78b76fc9903f6a85ab9b64e2b3751b8a6aa5811bb73f85ddfae
Stable URL of this page
https://metraipolis.com/documento/dc_f88e485759f9

How to cite

Longitudinal plasma proteomics identifies diagnostic and response-associated inflammatory and immune biomarkers in psoriasis following secukinumab therapy — Europe PMC PMID:42112372 — Europe PMC (en), https://europepmc.org/article/MED/42112372 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f88e485759f9 (Metraipolis archive dc_f88e485759f9, sha256 088ee5314df5a78b76fc9903f6a85ab9b64e2b3751b8a6aa5811bb73f85ddfae)
BibTeX
@misc{dcf88e485759f9,
  title = {Longitudinal plasma proteomics identifies diagnostic and response-associated inflammatory and immune biomarkers in psoriasis following secukinumab therapy — Europe PMC PMID:42112372},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42112372},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f88e485759f9; sha256 088ee5314df5a78b76fc9903f6a85ab9b64e2b3751b8a6aa5811bb73f85ddfae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42112372. Agents can read the archived copy with the MCP tool read_document.